Willow Biosciences Inc
TSX:WLLW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Willow Biosciences Inc
TSX:WLLW
|
CA |
|
Magillem Design Services SA
PAR:MLMGL
|
FR |
|
Q
|
Quest Diagnostics Inc
DUS:QDI
|
US |
|
U
|
Urban Outfitters Inc
XETRA:UOF
|
US |
|
U
|
Ultrapetrol (Bahamas) Ltd
OTC:ULTRF
|
BS |
|
G
|
Golden Energy Offshore Services AS
OSE:GEOS
|
NO |
|
KS Energy Ltd
SGX:578
|
SG |
|
Aquila Energy Efficiency Trust PLC
LSE:AEET
|
UK |
|
New Zealand Energy Corp
XTSX:NZ
|
NZ |
|
M
|
Miwon Specialty Chemical Co Ltd
KRX:268280
|
KR |
|
E
|
ELK-Desa Resources Bhd
KLSE:ELKDESA
|
MY |
|
Steppe Gold Ltd
TSX:STGO
|
MN |
|
A
|
Ads Maritime Holding Plc
OSE:ADS
|
NO |
|
Seaway 7 ASA
OSE:SEAW7
|
NO |
|
D
|
Daythree Digital Bhd
KLSE:DAY3
|
MY |
|
South Plains Financial Inc
NASDAQ:SPFI
|
US |
|
T
|
Trive Property Group Bhd
KLSE:TRIVE
|
MY |
Bankruptcy Probability
Willow Biosciences Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Willow Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Willow Biosciences Inc
TSX:WLLW
|
107m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Willow Biosciences Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Willow Biosciences Inc has total debt of 724k CAD. This includes both short-term (0 CAD) and long-term (724k CAD) debt.
You can find a full breakdown on its Balance Sheet.
